About the bill
S. 920 establishes a clinical care commission to evaluate and recommend solutions regarding better coordinating federal programs related to complex metabolic or autoimmune disorders, a disease resulting from insulin deficiency or resistance, or complications caused by any such disease. The bill requires the Commission to report its recommendations not later than three years after its first meeting. The bill sunsets the Commission at the end of fiscal year 2021.
Sponsor and status
115th Congress (2017–2019)
Enacted — Signed by the President on Nov 2, 2017
This bill was enacted after being signed by the President on November 2, 2017.
2 Cosponsors (1 Democrat, 1 Republican)
Position statements
What legislators are saying
“Olson/Shaheen Diabetes Bill Signed Into Law”
—
Rep. Pete Olson [R-TX22, 2009-2020]
on Nov 3, 2017
“The Week Ahead - scheduled votes, committee action and other important notes for the week of October 10, 2017”
—
Rep. David Young [R-IA3, 2015-2018]
on Oct 10, 2017
“Chairman Alexander: This Congress, HELP Committee Produced 18 Laws Including Landmark Opioid Legislation to Combat Nations Most Pressing Public Health Crisis”
—
Sen. Lamar Alexander [R-TN, 2003-2020]
on Dec 20, 2018
Incorporated legislation
This bill incorporates provisions from:
H.R. 309: National Clinical Care Commission Act
Passed House (Senate next) on Jan 9, 2017. 44% incorporated. (compare text)
History
|
Jan 9, 2017
|
|
Source Bill —
Passed House (Senate next)
This activity took place on a related bill, H.R. 309 (115th), possibly in lieu of similar activity on S. 920 (115th). |
|
Apr 24, 2017
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
Apr 26, 2017
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
|
Sep 6, 2017
|
|
Passed Senate (House next)
The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Unanimous Consent so no record of individual votes was made. |
|
Oct 11, 2017
|
|
Passed House
The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by voice vote so no record of individual votes was made. |
|
Nov 2, 2017
|
|
Enacted — Signed by the President
The President signed the bill and it became law.
|
S. 920 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number S. 920. This is the one from the 115th Congress.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“S. 920 — 115th Congress: National Clinical Care Commission Act.” www.GovTrack.us. 2017. September 22, 2023 <https://www.govtrack.us/congress/bills/115/s920>
- show another citation format:
- APA
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
